SLU-PP-332

SLU-PP-332 is a small-molecule research compound — not a peptide — studied as a pan-agonist of the estrogen-related receptors (ERRalpha, ERRbeta, ERRgamma). These nuclear receptors regulate mitochondrial biogenesis and oxidative metabolism. In preclinical rodent research, SLU-PP-332 has been investigated for upregulating fatty-acid oxidation and mitochondrial activity, which is why it is often described as a proposed exercise mimetic. Supplied at ≥98% purity for in-vitro research use only.

No. SLU-PP-332 is a synthetic small-molecule ERR agonist, not a peptide. It is studied for nuclear-receptor (ERR) agonism and downstream mitochondrial-metabolism pathways rather than the receptor activity of peptide compounds. Because it is a small molecule, its solubility and preparation differ from lyophilised peptides — researchers should follow their protocol's guidance for vehicle and working concentration. Not for human consumption — for research use only.

In research, an 'exercise mimetic' is a compound studied for its ability to reproduce some of the metabolic adaptations of physical exercise — such as increased fatty-acid oxidation and mitochondrial activity — through a pharmacological mechanism. SLU-PP-332 is investigated in this context because of its ERR-agonist activity in rodent models. These are preclinical research-model observations, not evidence of any effect in humans. Not for human consumption — for research use only.

SLU-PP-332 is supplied as a research-grade powder. Preparation depends on the experimental protocol and chosen solvent system; researchers should consult the published literature for appropriate vehicles and working concentrations for in-vitro assays. Storage: keep the powder sealed at −20°C, protected from moisture and light, for long-term stability. Prepared solutions should be stored per protocol and used promptly. Not for human consumption — for research use only.

Legal status: SLU-PP-332 is legal to purchase in Australia for legitimate laboratory research purposes. It is not for human consumption, therapeutic, cosmetic, or veterinary use and is not TGA-approved. Purchasers must be 18+ and confirm research-only intent. Quality: each batch is independently verified by third-party HPLC at ≥98% purity with a full COA including purity %, identity confirmation, and screening. Full COAs are available in our COA Library.

SLU-PP-332 works through a distinct mechanism from the incretin (GLP-1/GIP) agonists like Retatrutide or Tirzepatide and from NNMT inhibitors like 5-Amino-1MQ. Rather than acting on a cell-surface receptor or a single enzyme, it agonises the nuclear ERR receptors that govern mitochondrial and oxidative-metabolism gene programmes — which is why it is studied alongside, not in place of, those compounds in metabolic research. Not for human consumption — for research use only.

Peptide Warehouse Australia stocks SLU-PP-332 5mg and ships nationwide via Australia Post with full tracking. Orders placed before 12PM AEST dispatch the same business day from our Melbourne warehouse; orders after 12PM AEST dispatch the next business day. Standard Post $8.99 (2–6 business days); Express Post $13.99 (1–3 business days); free shipping on all orders over $199 AUD. All orders ship in discreet plain packaging with no external branding. Not for human consumption — for research use only.